Evaluation of 177Lu-Labeled Pertuzumab F(ab′)2 Fragments for HER2-Positive Cancer Targeting: A Comparative In Vitro and In Vivo Study
Article in Cancer Biotherapy & Radiopharmaceuticals (January 2024)
The most recent citing publications are shown below. View all 64 publications that cite this research output on Dimensions.
Article in Cancer Biotherapy & Radiopharmaceuticals (January 2024)
Article in International Journal of Molecular Sciences (July 2023)
Article in Cancer (December 2022)